TG Therapeutics, Inc. (TGTX)

Oncology Corporate Profile

Stock Performance

11.3750
-0.6250

3 Month Stock History Chart

HQ Location

3 Columbus Circle, 15th Floor
New York, NY 10019

Company Description

TG Therapeutics is an innovative, clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. Currently, the company is developing two therapies targeting hematological malignancies. TG-1101 (ublituximab) is a novel, glycol-engineered monoclonal antibody that targets a specific and unique epitope on the CD20 antigen found on mature B-lymphocytes. TG Therapeutics is also developing TGR-1202, an orally available PI3K delta inhibitor, jointly with Rhizen Pharmaceuticals S A. The delta isoform of PI3K is strongly expressed in cells of hematopoietic origin and is believed to be important in the proliferation and survival of B lymphocytes. Both TG-1101 and TGR-1202 are in clinical development for patients with hematologic malignancies. TG Therapeutics is headquartered in New York City.

Website: http://www.tgtherapeutics.com/

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
TGR-1202PI3K delta inhibitorIII
ublituximab / TG-1101 (+ ibrutinib)anti-CD20 monoclonal antibody (humanized)Chronic Lymphocytic Leukemia (CLL)III
TGR-1202PI3K delta inhibitorDiffuse Large B-Cell Lymphoma (DLBCL)III
TG-1101anti-CD20 monoclonal antibodyAcute Myelogenous Leukemia (AML)I
IRAK4kinase inhibitorChronic Lymphocytic Leukemia (CLL)Preclinical
IRAK4kinase inhibitorNon-Hodgkin's Lymphoma (NHL)Preclinical
IRAK4kinase inhibitorWaldenstrom macroglobulinemia (WM)Preclinical

View additional information on product candidates here »

Source: http://www.tgtherapeutics.com/

Recent News Headlines

8/21/2017 06:23 am

8/21/2017 06:23 am

8/21/2017 06:23 am

8/21/2017 06:23 am

8/21/2017 06:23 am

8/14/2017 06:20 am

8/14/2017 06:20 am

8/14/2017 06:20 am

8/14/2017 06:20 am

8/10/2017 06:19 am

8/10/2017 06:19 am

8/10/2017 06:19 am

8/10/2017 06:19 am

8/10/2017 06:19 am

8/9/2017 06:19 pm

8/9/2017 06:19 pm

8/9/2017 06:19 pm

8/9/2017 06:19 am

8/7/2017 06:20 am

8/1/2017 06:20 pm

8/1/2017 12:26 am

7/21/2017 06:19 am

7/14/2017 12:20 pm

6/28/2017 06:20 am

6/26/2017 06:20 am